Drug Shortage Report for CLINDAMYCIN IV INFUSION
Report ID | 200495 |
Drug Identification Number | 02408511 |
Brand name | CLINDAMYCIN IV INFUSION |
Common or Proper name | CLINDAMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CLINDAMYCIN |
Strength(s) | 12MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10LIIF |
ATC code | J01FF |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-31 |
Estimated end date | 2024-01-26 |
Actual end date | 2024-01-31 |
Shortage status | Resolved |
Updated date | 2024-02-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2024-02-01 | English | Compare |
v8 | 2024-01-31 | French | Compare |
v7 | 2024-01-31 | English | Compare |
v6 | 2024-01-03 | French | Compare |
v5 | 2024-01-03 | English | Compare |
v4 | 2023-08-01 | English | Compare |
v3 | 2023-07-31 | French | Compare |
v2 | 2023-07-31 | English | Compare |
v1 | 2023-07-31 | English | Compare |
Showing 1 to 9 of 9